Fibronectin fragment mediated cartilage chondrolysis. II. Reparative effects of anti-oxidants.
In an accompanying manuscript, it was shown that the cartilage chondrolytic activities of fibronectin fragments (Fn-f), which are mediated through catabolic cytokines such as TNF-alpha, IL-1 and IL-6, could be suppressed by anti-oxidants (AOs). The AOs neutralized reactive oxygen species (ROS) which are known to mediate catabolic cytokine action. The objective in this work was to test whether AOs would promote restoration of proteoglycan (PG) in Fn-f treated cartilage, since under normal culturing conditions, PG is not restored after removal of the Fn-f. Cartilage was first cultured with an amino-terminal 29-kDa Fn-f to cause loss of about half of the total PG and then treated with NAC (1 and 10 mM) or glutathione (10 microM) or DMSO (0.1 or 1%). Treatment with NAC and glutathione maximally caused restoration of PG within 14 days to normal or supernormal levels, while DMSO was less effective. Catalase, but not superoxide dismutase, enhanced PG content to a small but significant extent. The restoration of PG in Fn-f treated cartilage occurred throughout the full depth of the cartilage slices as shown by histochemical analysis. However, removal of the AO allowed a subsequent decrease in PG content suggesting that the AOs had not blocked cytokine expression but had merely suppressed cytokine activities. Addition of NAC to IL-1 treated cartilage promoted a restoration of PG, while addition to chymopapain or trypsin treated cartilage was not very effective, suggesting that the effect of AOs requires a cytokine driven damage system. We conclude that the AOs promote a restoration of PG in the Fn-f treated cartilage by suppressing the effects of catabolic cytokines. The data suggest a potential for AOs in reversing tissue damage caused by cytokines.
Homandberg
G A
GA
Department of Biochemistry, Rush Medical College, Rush-Presbyterian-St. Luke's Medical Center, Chicago, IL 60612-3864, USA.
Hui
F
F
Wen
C
C
D000111:Acetylcysteine / Q000494:pharmacology; D000818:Animals; D000975:Antioxidants / Q000494:pharmacology*; D002358:Cartilage, Articular / Q000166:cytology / Q000378:metabolism*; D002374:Catalase / Q000494:pharmacology; D002417:Cattle; D002917:Chymopapain / Q000494:pharmacology; D046508:Culture Techniques; D004121:Dimethyl Sulfoxide / Q000494:pharmacology; D005353:Fibronectins / Q000737:chemistry / Q000502:physiology*; D005978:Glutathione / Q000494:pharmacology; D007375:Interleukin-1 / Q000494:pharmacology; D010446:Peptide Fragments; D011509:Proteoglycans / Q000378:metabolism*; D013482:Superoxide Dismutase / Q000494:pharmacology; D014357:Trypsin / Q000494:pharmacology
D000975:Antioxidants; D005353:Fibronectins; D007375:Interleukin-1; D010446:Peptide Fragments; D011509:Proteoglycans; D002374:Catalase; D013482:Superoxide Dismutase; D014357:Trypsin; D002917:Chymopapain; D005978:Glutathione; D000111:Acetylcysteine; D004121:Dimethyl Sulfoxide